Searchable abstracts of presentations at key conferences in endocrinology

ea0085p73 | Miscellaneous 2 | BSPED2022

Central precocious puberty in a patient with short stature and skeletal abnormalities in KBG syndrome due to ANKRD11 variant

Blackburn James , Calder Alistair , Gevers Evelien

Introduction: Underlying causes of short stature are difficult to establish and many patients with short stature do not have a clear diagnosis. Careful examination and investigation of patients with short stature may identify additional features that help to make a diagnosis or direct genetic testing. Here we describe a patient with severe short stature with additional features on examination and skeletal survey in keeping with KBG syndrome. In addition, the patient developed ...

ea0078p53 | Pituitary and Growth | BSPED2021

SGA, short stature, brachydactyly and joint stiffness due to SMAD4 variants in Myhre syndrome

Ramakrishnan Anand , Yakoop Silvia , Lim Sharon , Willemsen Ruben , Calder Alistair , Gevers Evelien

We present 3 children in a single centre with Myhre syndrome (MS) due to a heterozygous SMAD4 Ile500val mutation. Consistent features were brachydactyly, joint restriction, muscular hypertrophy, genital abnormalities, conductive hearing loss and developmental delay. SGA and height were variable. Diagnosis was made by next generation sequencing in patients 1 and 3 and on the skeletal survey in patient 2. Retrospectively, features of Myhre syndrome were present on the s...

ea0058p009 | Bone | BSPED2018

A case of persistent hypercalcaemia, following accidental denosumab administration

Paltoglou George , Brain Caroline , Amin Rakesh , Durani Sina , Rajamoorthy Vidhooshni , Esther Freeman , Braha Nirit , De Keyser Paul , Calder Alistair , Allgrove Jeremy

Introduction: Denosumab, a human monoclonal antibody that inhibits activation of osteoclasts provides sustained suppression of bone turnover in osteolytic bone disease. Denosumab has rarely been associated with late hypercalcaemia following therapeutic administration for bone tumours in children, bone metastases in adults and in children with Osteogenesis Imperfecta Type VI.Case report: A male child of Indian origin was referred for advice to GOSH from a...

ea0070aep457 | Diabetes, Obesity, Metabolism and Nutrition | ECE2020

Real-life clinical experience with GLP1 analogs and SGLT2 inhibitors in the treatment of diabetes type 2 and obesity

Pérez-Rodríguez José , Calderón-Vicente Dulce , González-López Javier , Martín-Iglesias David , Alramadan Mubarak

Objectives: SGLT2 inhibitors and GLP1 analogs are the treatment of choice after metformin in patients with type 2 diabetes (DM2) and overweight-obesity (OB). The aim of this study is to analyze the effectiveness and safety of these treatments alone or in combination.Methodology: This is a retrospective observational study in the usual clinical practice. We analyzed the effects of SGLT2 inhibitors and GLP1 analogs treatments in patients with DM2 and OB wh...

ea0030oc2.6 | Oral Communications 2 | BSPED2012

Childhood body composition is associated with maternal plasma polyunsaturated fatty acids status in late pregnancy

Moon Rebecca J , Harvey Nicholas C , Ntani Georgia , Davies Justin H , Inskip Hazel M , Godfrey Keith , Dennison Elaine M , Calder Philip , Cooper Cyrus

Introduction: Maternal diet during pregnancy has been linked to offspring body composition, but the specific nutrients and mechanisms involved are not well understood. Higher n-3 polyunsaturated fatty acid (PUFA) status is associated with lower risk of adiposity in adults, whereas n-6 PUFA are adipogenic. The effect of maternal PUFA in determining offspring body composition is unknown.Method: We evaluated the relationships between maternal ...